Epitherapeutics

EpiTherapeutics is developing novel anticancer drugs based on epigenetics, a therapeutic area researched by the renowned scientist Professor Kristian Helin and his research team at the Biotech Research and Innovation Centre (BRIC) of the University of Copenhagen. EpiTherapeutics' development program focuses on enzymes involved in the transcriptional regulation of cancer.